A great postdoc opportunity from a great PI just launching his new lab!

What Three Decades of Caring for Patients Taught One Researcher About Making Healthcare Work Better  healthcity.bmc.org/what-thre…

Kudos to Dr. Valerie Gouon-Evans @CReM_Boston : BMC Researcher Aims to Use Regenerative Medicine to Change the Future of Liver Disease Treatment healthcity.bmc.org/regenerat…

Police Remove Diabetes Experts From Conference for Distributing Critique of Trump Administration nytimes.com/2026/06/05/well/…

Shame on the American Diabetes Association for calling the police on its own (‼️) Journal Editor & #ADA2026 presenters. If I were a donor I would withdraw my donation today. The board should issue an apology and resign now! Watch clip, see details below 👇🏼

Another great PhD thesis defense this week @CReM_Boston, this one from newly minted Dr. Julian Amirault of the @GMostoslavsky Lab, focused on the generation of human iPSC-derived CD4+ T cells! Congrats, Dr. Amirault!

Helpful synopsis in @Nature of the harms inherent in the White House's proposed changes to NIH funding: "White House proposes vast overhaul of US science funding: what you need to know" nature.com/articles/d41586-0…

Congrats Dr. Vanuytsel @CReM_Boston: BMC Researcher Aims to Build More Options, Access for Sickle Cell Disease Treatment  - HealthCity healthcity.bmc.org/bmc-resea…

So excited to share that the first paper from the Lung Disease Lab is now published in JCI Insight! I’m exceptionally grateful to all our collaborators and proud of the team, particularly Declan Turner for driving this work over the line! Read more here: lnkd.in/gTnRGiQJ

Our hands-on cell culture course @CReM_Boston for making lung out of iPSCs has kicked off and is running all week. Those smiles you see are from day 2: making endoderm, the first step to engineering lung epithelium! #itsthecells! #helpisontheway! @BU_Tweets @The_BMC

Miriam O'Day, A1F Senior Policy Consultant, is representing the Alpha-1 Foundation at the 2026 NORD Rare Disease Scientific Symposium in Arlington, VA. This year's theme, "Advancing Innovation in Rare Disease Research," brings together a dynamic community of researchers, clinicians, industry leaders, and advocates to spark the conversations and connections that drive science forward. @RareDiseases

Congratulations to Dr. Christine Reardon for receiving the Henry D. Chadwick Medal at MTS 2026! You are so loved by your colleagues, trainees, and patients. We thank you for your expertise in intensive care medicine, lung cancer, and neuromuscular respiratory disease.

Congrats to Dr. Andrew Wilson's Lab and MD/PhD student/first author, Carly Merritt on their new paper: "AT2-intrinsic Z-AAT expression drives conserved inflammatory and proteotoxic stress responses and predisposes to emphysema" biorxiv.org/content/10.64898…

Congratulations to Dr. Chris Reardon, this years Chadwick Medal awardee ⁦@MassThoracic⁩ 2026! Our once and always program director ⁦@The_BMC⁩ Pulmonary.

Great to be at the Mass Thoracic Society 2026 ⁦@MassThoracic⁩ annual meeting where MTS President Finn Hawkins is now kicking off the day!

Base editing in vivo is here! so exciting! Beam Therapeutics Announces Update on BEAM-302 for alpha-1 antitrypsin deficiency .alpha1.org/beam-therapeutics…

Today, Beam announced updated safety and efficacy data from the ongoing Phase 1/2 trial of BEAM-302 in alpha-1 antitrypsin deficiency (AATD) and the selection of 60 mg as the optimal biological dose to advance into pivotal development to support potential accelerated approval.

The Kotton Lab announces our latest biorxiv posting; a collaboration with the labs of Jessie Huang @hjhjess and Will Zacharias. "The chromatin remodeling complex PRC2 safeguards cell fate in alveolar epithelial type 2 cells" biorxiv.org/content/10.64898…